Medicine
fromFortune
2 days agoSanofi CEO: The enterprise AI shift will reshape pharma in 2026 | Fortune
AI is shifting from experimentation to enterprise-scale operationalization, becoming a durable engine of transformation reshaping work, R&D, supply chains, and drug discovery.